Vanguard Group
IBRX icon

Vanguard Group’s ImmunityBio IBRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$57.6M Buy
21,817,307
+1,472,753
+7% +$3.89M ﹤0.01% 2063
2025
Q1
$61.2M Buy
20,344,554
+3,016,325
+17% +$9.08M ﹤0.01% 2010
2024
Q4
$44.4M Buy
17,328,229
+425,713
+3% +$1.09M ﹤0.01% 2214
2024
Q3
$62.9M Buy
16,902,516
+3,070,720
+22% +$11.4M ﹤0.01% 2078
2024
Q2
$87.4M Buy
13,831,796
+292,206
+2% +$1.85M ﹤0.01% 1898
2024
Q1
$72.7M Buy
13,539,590
+211,065
+2% +$1.13M ﹤0.01% 2016
2023
Q4
$66.9M Sell
13,328,525
-1,347,162
-9% -$6.76M ﹤0.01% 2068
2023
Q3
$24.8M Buy
14,675,687
+4,342,386
+42% +$7.34M ﹤0.01% 2465
2023
Q2
$28.7M Buy
10,333,301
+2,047,343
+25% +$5.69M ﹤0.01% 2431
2023
Q1
$15.1M Buy
8,285,958
+30,712
+0.4% +$55.9K ﹤0.01% 2729
2022
Q4
$41.9M Buy
8,255,246
+175,705
+2% +$891K ﹤0.01% 2267
2022
Q3
$40.2M Buy
8,079,541
+557,164
+7% +$2.77M ﹤0.01% 2290
2022
Q2
$28M Buy
7,522,377
+366,231
+5% +$1.36M ﹤0.01% 2478
2022
Q1
$40.1M Buy
7,156,146
+17,609
+0.2% +$98.8K ﹤0.01% 2410
2021
Q4
$43.4M Buy
7,138,537
+107,279
+2% +$652K ﹤0.01% 2432
2021
Q3
$68.5M Buy
7,031,258
+1,471,235
+26% +$14.3M ﹤0.01% 2191
2021
Q2
$79.4M Buy
5,560,023
+3,000,632
+117% +$42.8M ﹤0.01% 2116
2021
Q1
$60.8M Buy
2,559,391
+531,509
+26% +$12.6M ﹤0.01% 2209
2020
Q4
$27M Buy
2,027,882
+161,614
+9% +$2.15M ﹤0.01% 2494
2020
Q3
$12.9M Buy
1,866,268
+133,225
+8% +$924K ﹤0.01% 2662
2020
Q2
$21.3M Buy
1,733,043
+341,483
+25% +$4.19M ﹤0.01% 2394
2020
Q1
$4.01M Buy
1,391,560
+318,040
+30% +$916K ﹤0.01% 3061
2019
Q4
$4.07M Buy
1,073,520
+174
+0% +$659 ﹤0.01% 3234
2019
Q3
$1.31M Buy
1,073,346
+100,225
+10% +$122K ﹤0.01% 3570
2019
Q2
$993K Sell
973,121
-386,555
-28% -$394K ﹤0.01% 3681
2019
Q1
$2.15M Buy
1,359,676
+125,280
+10% +$198K ﹤0.01% 3425
2018
Q4
$1.43M Buy
1,234,396
+3,691
+0.3% +$4.28K ﹤0.01% 3463
2018
Q3
$4.55M Buy
1,230,705
+2,508
+0.2% +$9.28K ﹤0.01% 3271
2018
Q2
$3.76M Sell
1,228,197
-432,812
-26% -$1.32M ﹤0.01% 3307
2018
Q1
$6.46M Sell
1,661,009
-178,378
-10% -$694K ﹤0.01% 3041
2017
Q4
$8.26M Buy
1,839,387
+241,784
+15% +$1.09M ﹤0.01% 2904
2017
Q3
$8.75M Buy
1,597,603
+109,914
+7% +$602K ﹤0.01% 2876
2017
Q2
$11.3M Sell
1,487,689
-595,017
-29% -$4.52M ﹤0.01% 2717
2017
Q1
$7.39M Buy
2,082,706
+160,510
+8% +$570K ﹤0.01% 2891
2016
Q4
$11M Buy
1,922,196
+88,033
+5% +$504K ﹤0.01% 2700
2016
Q3
$14.3M Buy
1,834,163
+250,878
+16% +$1.95M ﹤0.01% 2518
2016
Q2
$9.85M Buy
1,583,285
+193,338
+14% +$1.2M ﹤0.01% 2655
2016
Q1
$11.4M Buy
1,389,947
+654,682
+89% +$5.38M ﹤0.01% 2543
2015
Q4
$12.7M Buy
735,265
+689,898
+1,521% +$12M ﹤0.01% 2503
2015
Q3
$519K Buy
+45,367
New +$519K ﹤0.01% 3842